5-HT2 receptor antagonism reduces hyperactivity induced by amphetamine, cocaine, and MK-801 but not D1 agonist C-APB
about
The role of serotonin 5-HT2A receptors in memory and cognitionBlockade of Serotonin 5-HT2A Receptors Suppresses Behavioral Sensitization and Naloxone-Precipitated Withdrawal Symptoms in Morphine-Treated MiceElevated Expression of Serotonin 5-HT(2A) Receptors in the Rat Ventral Tegmental Area Enhances Vulnerability to the Behavioral Effects of CocaineAnimal models of serotonergic psychedelics.Serotonergic system and attention deficit hyperactivity disorder (ADHD): a potential susceptibility locus at the 5-HT(1B) receptor gene in 273 nuclear families from a multi-centre sample.Impact of metabotropic glutamate 2/3 receptor stimulation on activated dopamine release and locomotionPharmacological treatment of schizophrenia: a critical review of the pharmacology and clinical effects of current and future therapeutic agents.N-substituted piperazines abused by humans mimic the molecular mechanism of 3,4-methylenedioxymethamphetamine (MDMA, or 'Ecstasy').Influence of candidate genes on attention problems in children: a longitudinal studyEvaluation of N-desmethylclozapine as a potential antipsychotic--preclinical studies.Pimavanserin, a serotonin(2A) receptor inverse agonist, for the treatment of parkinson's disease psychosis.Review: Genetics of attention deficit/hyperactivity disorder.Serotonin 2A Receptor Gene Polymorphism in Korean Children with Attention-Deficit/Hyperactivity DisorderRole of the serotonin system in ADHD: treatment implications.The preferential dopamine D3 receptor antagonist S33138 inhibits cocaine reward and cocaine-triggered relapse to drug-seeking behavior in rats.Hypothesis-driven medication discovery for the treatment of psychostimulant addictionAttenuation of the effects of d-amphetamine on interval timing behavior by central 5-hydroxytryptamine depletion.The role of serotonin in the NMDA receptor antagonist models of psychosis and cognitive impairment.Gestational exposure to perfluorooctanoic acid (PFOA): Alterations in motor related behaviors.A short history of the 5-HT2C receptor: from the choroid plexus to depression, obesity and addiction treatment.Blockade of nucleus accumbens 5-HT2A and 5-HT2C receptors prevents the expression of cocaine-induced behavioral and neurochemical sensitization in rats.Locomotor activity induced by noncompetitive NMDA receptor antagonists versus dopamine transporter inhibitors: opposite strain differences in inbred long-sleep and short-sleep mice.The selective serotonin-2A receptor antagonist M100907 reverses behavioral deficits in dopamine transporter knockout mice.Serotonin and Dopamine Candidate Gene Variants and Alcohol- and Non-Alcohol-Related Aggression.Evidence for the serotonin HTR2A receptor gene as a susceptibility factor in attention deficit hyperactivity disorder (ADHD).Tph2 gene deletion enhances amphetamine-induced hypermotility: effect of 5-HT restoration and role of striatal noradrenaline release.
P2860
Q26779278-82878BFB-E67B-4CFC-B34D-58236F9FF369Q28354201-F87E2BAF-124D-41BA-80B6-78E893D1BE99Q29346961-7BE9694B-52A0-45F6-B007-0506A5911E99Q30444312-FADAA783-393B-4FC5-AC96-6BEBE6C8B79AQ34145729-50BBC542-BBEC-4631-B06A-7CDCB43E7A20Q34197072-5C98D941-4325-4A04-87BD-DD4F2443C4B0Q34274859-F6D1893A-B6A9-4596-BAAA-AADFB300D319Q34360861-3E78F65E-1F95-4580-92F2-741D0C8604E7Q34533652-D6B59FF9-1091-42F2-83A8-B2E651E29452Q34590400-BCD8EA5F-86FB-49CE-8A93-F5A6B1C6736BQ34660675-F8E967D0-5871-47FD-B21A-072CFF7C26DCQ34784505-609EA5DE-60FB-413E-95BC-64CE8EC0D87DQ36229935-4D00CDCB-75C8-4226-B88D-9B2F66EDB3C1Q36972698-D35BB8AB-49AF-426C-80E6-D1F7BF70E806Q37052544-0D20B2B4-8AC9-4C18-AF43-D3A583515615Q37183687-EBF58059-B769-4152-B249-769D5976C799Q37386493-B0495C66-DAE3-44D8-80E7-75BF31713DF3Q37826638-B8EA07AB-6A23-44D0-A0CD-4BEFEB540C9FQ39153097-4EA362F1-30F9-4BFD-A58F-E9395CC74C54Q39164871-E1769246-52E8-44BA-8FFE-A44167E2051EQ41876191-9F368752-6E49-46FB-816B-5CE8344EBAB7Q43974350-02776B7A-7063-4070-9E2F-7E6093E4E7A0Q44645827-3974216B-9382-437A-8356-86E3CFF540F8Q48081384-96B161DE-DB18-491A-B5BD-F630F90D846EQ51973109-B0AB3726-B6B1-4868-B06D-8A89B344D722Q52307553-B3C0AF8C-DE4B-4C04-9594-8CB255A01663
P2860
5-HT2 receptor antagonism reduces hyperactivity induced by amphetamine, cocaine, and MK-801 but not D1 agonist C-APB
description
1999 nî lūn-bûn
@nan
1999 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հունիսին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年学术文章
@wuu
1999年学术文章
@zh-cn
1999年学术文章
@zh-hans
1999年学术文章
@zh-my
1999年学术文章
@zh-sg
1999年學術文章
@yue
name
5-HT2 receptor antagonism redu ...... K-801 but not D1 agonist C-APB
@ast
5-HT2 receptor antagonism redu ...... K-801 but not D1 agonist C-APB
@en
5-HT2 receptor antagonism redu ...... K-801 but not D1 agonist C-APB
@nl
type
label
5-HT2 receptor antagonism redu ...... K-801 but not D1 agonist C-APB
@ast
5-HT2 receptor antagonism redu ...... K-801 but not D1 agonist C-APB
@en
5-HT2 receptor antagonism redu ...... K-801 but not D1 agonist C-APB
@nl
prefLabel
5-HT2 receptor antagonism redu ...... K-801 but not D1 agonist C-APB
@ast
5-HT2 receptor antagonism redu ...... K-801 but not D1 agonist C-APB
@en
5-HT2 receptor antagonism redu ...... K-801 but not D1 agonist C-APB
@nl
P2093
P1476
5-HT2 receptor antagonism redu ...... K-801 but not D1 agonist C-APB
@en
P2093
C L Heron-Maxwell
M F O'Neill
P304
P356
10.1016/S0091-3057(98)00240-8
P407
P577
1999-06-01T00:00:00Z